Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Engelman

Showing results (41-50 of 238) with videos related to

Pageof 24
Sort By:
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|June 23, 2012
Genetic changes in squamous cell lung cancer: a reviewRebecca S Heist, Lecia V Sequist, Jeffrey A Engelman
Nucleic Acids Research|May 25, 1991
A rapid in vitro assay for HIV DNA integrationR Craigie, K Mizuuchi, F D Bushman, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 21, 2010
The PI3K pathway as drug target in human cancerKevin D Courtney, Ryan B Corcoran, Jeffrey A Engelman
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 12, 2005
Epidermal growth factor receptor mutations in non-small-cell lung cancer: implications for treatment and tumor biologyPasi A Jänne, Jeffrey A Engelman, Bruce E Johnson
Current Opinion in Genetics & Development|December 17, 2009
Targeting the PI3K signaling pathway in cancerKwok-Kin Wong, Jeffrey A Engelman, Lewis C Cantley
FEBS Letters|April 28, 1999
Sequence and detailed organization of the human caveolin-1 and -2 genes located near the D7S522 locus (7q31.1). Methylation of a CpG island in the 5' promoter region of the caveolin-1 gene in human breast cancer cell linesJ A Engelman, X L Zhang, M P Lisanti
Cancer Discovery|April 22, 2015
The BCL2 Family: Key Mediators of the Apoptotic Response to Targeted Anticancer TherapeuticsAaron N Hata, Jeffrey A Engelman, Anthony C Faber
The EMBO Journal|January 10, 1998
Critical contacts between HIV-1 integrase and viral DNA identified by structure-based analysis and photo-crosslinkingT M Jenkins, D Esposito, A Engelman, et al.
Nature Cancer|February 4, 2022
The present and future of PI3K inhibitors for cancer therapyPau Castel, Eneda Toska, Jeffrey A Engelman, et al.
The Journal of Biological Chemistry|March 29, 1996
A soluble active mutant of HIV-1 integrase: involvement of both the core and carboxyl-terminal domains in multimerizationT M Jenkins, A Engelman, R Ghirlando, et al.
Pageof 24

Showing results (41-50 of 238) with videos related to

Sort By:
Pageof 24
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|June 23, 2012
Genetic changes in squamous cell lung cancer: a reviewRebecca S Heist, Lecia V Sequist, Jeffrey A Engelman
Nucleic Acids Research|May 25, 1991
A rapid in vitro assay for HIV DNA integrationR Craigie, K Mizuuchi, F D Bushman, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 21, 2010
The PI3K pathway as drug target in human cancerKevin D Courtney, Ryan B Corcoran, Jeffrey A Engelman
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 12, 2005
Epidermal growth factor receptor mutations in non-small-cell lung cancer: implications for treatment and tumor biologyPasi A Jänne, Jeffrey A Engelman, Bruce E Johnson
Current Opinion in Genetics & Development|December 17, 2009
Targeting the PI3K signaling pathway in cancerKwok-Kin Wong, Jeffrey A Engelman, Lewis C Cantley
FEBS Letters|April 28, 1999
Sequence and detailed organization of the human caveolin-1 and -2 genes located near the D7S522 locus (7q31.1). Methylation of a CpG island in the 5' promoter region of the caveolin-1 gene in human breast cancer cell linesJ A Engelman, X L Zhang, M P Lisanti
Cancer Discovery|April 22, 2015
The BCL2 Family: Key Mediators of the Apoptotic Response to Targeted Anticancer TherapeuticsAaron N Hata, Jeffrey A Engelman, Anthony C Faber
The EMBO Journal|January 10, 1998
Critical contacts between HIV-1 integrase and viral DNA identified by structure-based analysis and photo-crosslinkingT M Jenkins, D Esposito, A Engelman, et al.
Nature Cancer|February 4, 2022
The present and future of PI3K inhibitors for cancer therapyPau Castel, Eneda Toska, Jeffrey A Engelman, et al.
The Journal of Biological Chemistry|March 29, 1996
A soluble active mutant of HIV-1 integrase: involvement of both the core and carboxyl-terminal domains in multimerizationT M Jenkins, A Engelman, R Ghirlando, et al.
Pageof 24